NYSE · BRK-B
Berkshire Hathaway Inc.
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
Loading market information…
NYSE · MRSH · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Marsh & McLennan Companies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Marsh & McLennan Companies, Inc.’s forward annual dividend is $3.96 per share, paid quarterly. The forward yield is 2.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Marsh & McLennan Companies, Inc.’s next earnings report is currently expected on Feb 4, 2027, with estimated earnings per share of $2.20. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Marsh & McLennan Companies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands. These include Marsh, renowned for its insurance brokerage services; Guy Carpenter, a specialist in risk and reinsurance; Mercer, which provides comprehensive human resources and investment-related financial advice; and Oliver Wyman Group, an influential management and economic consultancy. Marsh & McLennan structures its operations into two core business segments. The "Risk and Insurance Services" division encompasses activities such as risk management, along with comprehensive insurance and reinsurance brokerage and services. The "Consulting" division offers a broad spectrum of services, including health, retirement, talent, and investment consulting, as well as specialized advice in management, economics, and brand strategy. The Risk and Insurance Services segment's operations are primarily conducted through Marsh and Guy Carpenter, while Mercer and Oliver Wyman Group are the key contributors to the Consulting segment's offerings.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 17, 2025 | $2.72+1.87% vs estimate | $6.97B+0.51% vs estimate |
|---|
| Q1 2025 | Apr 17, 2025 | $3.06+1.32% vs estimate | $7.06B-0.22% vs estimate |
|---|
| Q4 2024 | Jan 30, 2025 | $1.87+6.25% vs estimate | $6.07B+1.78% vs estimate |
|---|
THE ANALYST VIEW
34 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 7 contributors · Median target $200.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$343.58+$4.28 (+1.26%)
JPMorgan Chase & Co.’s quoted price sits in the upper half of its reported 52-week range, 6.25% below the high.
$268.20+$7.78 (+2.99%)
Arthur J. Gallagher & Co.’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$321.64+$5.92 (+1.88%)
Aon plc’s quoted price sits in the lower half of its reported 52-week range, 15.88% below the high.
$320.73-$0.90 (-0.28%)
Willis Towers Watson Public Limited Company’s quoted price sits in the upper half of its reported 52-week range, 8.76% below the high.
$67.84+$1.96 (+2.98%)
Brown & Brown, Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.85% below the high.
$43.28+$0.66 (+1.55%)
Ryan Specialty Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 26.57% below the high.
$31.83-$0.12 (-0.38%)
The Baldwin Insurance Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.69% below the high.
